Global Genetic Testing Market Research Report 2023: A Complex Market With Unlimited Potential - Opportunities, Challenges, and Forecasts for the Next Five Years

News provided by

Oct 27, 2023, 10:15 ET

DUBLIN, Oct. 27, 2023 /PRNewswire/ -- The "Genetic Testing Markets. Global Market Analysis with Forecasts by Applications, Technologies, Products and Users with Executive and Consultant Guides 2023 to 2027" report has been added to ResearchAndMarkets.com's offering.

This research report provides you with the expertise to make informed investment decisions and valuations with confidence, thanks to the latest data and insights.

The genetic testing industry is experiencing unlimited growth potential, having crossed the chasm and now expanding in various areas. This growth presents both opportunities and challenges that need to be understood.

Genetics plays an increasingly crucial role in understanding health and disease, with new knowledge emerging and genetic testing becoming more affordable. This trend is driving the genetic testing industry to unprecedented growth. Moreover, new drugs are being developed that may only be effective for individuals with specific genetic profiles, further fueling the demand for genetic testing.

The traditional genetic testing market is not only growing in volume but also expanding its range of tests, leading to both new possibilities and challenges for the industry. The report provides detailed insights into 14 countries and 5 regions, helping you understand the global landscape of genetic testing.

The report also delves into areas like predictive diagnostics, pharmacogenomic testing, and direct-to-consumer genetic testing, explaining the technology and terminology in clear terms. It highlights the key issues, opportunities, and potential pitfalls in these areas.

By reading this report, you can gain a comprehensive understanding of growth expectations and market forecasts for the genetic testing industry over the next five years. It's an essential resource for anyone looking to navigate and invest in this rapidly evolving field.

Market Guides

Genetic Testing - Strategic Situation Analysis & Company Rankings
Selected Genetic Testing Companies Revenue & Growth
Selected Companies Growth Chart
Guide for Executives, Marketing, Sales and Business Development Staff
Guide for Management Consultants and Investment Advisors

Introduction and Market Definition

Genetic Testing Definition in This Report
The Genomics Revolution
Market Definition
Revenue Market Size
Newborn Screening
Non Invasive Pregnancy Testing
Predictive
Oncology
Direct to Consumer
Other Application
PCR
NGS
Cytogenetic
Other Technology
Methodology

Market Overview

Players in a Dynamic Market
Academic Research Lab
Diagnostic Test Developer
Instrumentation Supplier
Chemical/Reagent Supplier
Pathology Supplier
Independent Clinical Laboratory
Public National/regional Laboratory
Hospital Laboratory
Physicians Office Lab (POLS)
Audit Body
Certification Body
Genetic Tests - Types, Examples and Discussion
Preimplantation Genetic Diagnosis - An Emerging Market
Prenatal Diagnosis - New Technologies Create Opportunity
Newborn Screening
Diagnostic Testing
Carrier Testing
Predictive and Presymptomatic Testing
Pharmacogenomics
Forensic Testing
Parental Testing
Ancestral Testing
Industry Structure
Hospital's Testing Share
Economies of Scale
Hospital vs. Central Lab
Physician Office Lab's
Physician's and POCT

Market Trends

Factors Driving Growth

Genetic Discoveries Creating New Diagnostic Markets
The Aging Effect
Pharmacogenomics Drives Further Growth
Oncology and Liquid Biopsy Enter New Era
Fertility Practice Growth drives market
Direct to Consumer begins to break out

Factors Limiting Growth

Increased Competition Lowers Price
Lower Costs
Testing usage analysis curtailing growth
Wellness has a downside

Instrumentation, Automation and Diagnostic Trends

Traditional Automation and Centralization
The New Automation, Decentralization and Point of Care
Instruments Key to Market Share
Bioinformatics Plays a Role
PCR Takes Command
Next Generation Sequencing Fuels a Revolution
NGS Impact on Pricing
Whole Genome Sequencing, A Brave New World
Companion Diagnostics Blurs Diagnosis and Treatment
Shifting Role of Diagnostics

Genetic Testing Recent Developments

Novitas Rescinds Coverage for Multiple Genetic Tests
PerkinElmer (now Revvity) Becomes Dx Life Science Firm
New POC Genotyping Tests Based on Electromagnetic Detection
GenoMe Dx Launching dPCR Cancer Test
mDetect To Trial Breast Cancer Liquid Biopsy
Genomics England, Aims to Sequence 100K Newborns
Juno Diagnostics NIPT With At-Home Sample Collection
Cardio Diagnostics Launches Genetic Cario Risk Test
Universal Genetic Testing in Breast Cancer Further Supported
Aniling Gets CE-IVD Marks for Cancer Sequencing Tests
MyOme Lands Investment for WGS
Type 2 Diabetes GWAS Enables Risk Prediction
LetsGetChecked to Acquire Veritas Genetics
Guardant Health Plans New Comprehensive Assay
Tesis Labs Raises $20M
Sema4: Sema4 Elements
Clarified Precision Medicine Acquires Interpares Biomedicine
Genetic Technologies to Acquire DTC Genetic Test Provider EasyDNA
Illumina, Belgium Genetic Centers Partner on WGS-Based Dx
NIH, Genomics England Launch Sequencing Studies Using Nanopore Technology
Progenity Revenues Fall on COVID-19 Effect
Natera Launches Tumor Genomic Profiling Assay
23andMe To Go Public
Guardant Health to Offer Tumor Tissue Sequencing
Ancestry Quits Health Offering
DTC Firm MyDNA Merges With Gene by Gene
Aetna Coverage for NIPT to Include All Pregnancies
Agios Pharmaceuticals, PerkinElmer Partner on Hereditary Anemia Genetic Testing
Tumor, Germline Testing of Cancer Patients Can Give Discordant Results

Profiles of Key Companies

10x Genomics, Inc.
23andME Inc.
Abbott Laboratories
Adaptive Biotechnologies
Admera Health, LLC
Agilent/Dako
Akonni Biosystems
Amoy Diagnostics Co., Ltd.
Ancestry.com LLC
Anchor Dx
Baylor Miraca Genetics Laboratories
Beckman Coulter Diagnostics
Becton, Dickinson and Company
BGI Genomics Co. Ltd
BioGenex
Biolidics Ltd
bioMerieux Diagnostics
Bioneer Corporation
Bio-Rad Laboratories, Inc
Bio-Techne
C2i Genomics
CareDx
Caris Molecular Diagnostics
CellMax Life
Centogene
Cepheid (Danaher)
Complete Genomics, Inc. - A BGI Company
CosmosID
Dante Labs.
Datar Cancer Genetics Limited
Diasorin S.p.A.
Element Biosciences
Element Biosciences
Epic Sciences
Freenome
Fujirebio
Fulgent Genetics
Gene by Gene, Ltd.
Genedrive
GeneFirst Ltd.
Genetron Holdings
Genomics England
Genomics Personalized Health (GPH)
HeiScreen
Helix
Helix OpCo
Helomics
Hologic
HTG Molecular Diagnostics
Human Longevity, Inc.
iCellate
Illumina
Incell Dx
Inivata
Integrated Diagnostics
Macrogen
MDNA Life SCIENCES, Inc.
MDx Health
Medgenome
Menarini Silicon Biosystems
Meridian Bioscience
Mesa Biotech (Thermo Fisher)
Mesa Laboratories, Inc.
Metabiomics Corp
miR Scientific
MNG Labs
NantHealth, Inc.
Natera
Nebula Genomics
Oncocyte
OncoDNA
OpGen
ORIG3N, Inc.
Origene Technologies
Oxford Nanopore Technologies
Pacific Biosciences
Panagene
PathoQuest S.A.
Perkin Elmer (now Revvity)
Personal Genome Diagnostics
Qiagen
QuantuMDx
Roche Molecular Diagnostics
Roswell Biotechnologies
Seegene
Sema4 Holdings
Sequencing.com
Siemens Healthineers
simfo GmbH
Singlera Genomics Inc.
Singular Genomics
SkylineDx
Standard BioTools
Sure Genomics, Inc.
Sysmex
Vela Diagnostics
Volition
Vyant Bio
Zymo Research Corp

For more information about this report visit https://www.researchandmarkets.com/r/dbohfs

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets